Aspreva Pharmaceuticals to Present at the CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference



    VICTORIA, April 4 /CNW/ - Aspreva Pharmaceuticals Corporation (NASDAQ:  
ASPV; TSX: ASV) today announced that Bruce Cousins, EVP and CFO, will be
presenting at the CIBC World Markets Biotechnology and Specialty
Pharmaceuticals Conference in New York.
    The 25 minute presentation will be followed by a 25 minute question and
answer session. Mr. Cousins' presentation will take place on Thursday,
April 12th at 1:20 pm ET at the Millennium Broadway Hotel.
    A live audio web cast of the presentation will be available to all
interested parties through a link posted on Aspreva's website at
www.aspreva.com in the Investors section.

    About Aspreva Pharmaceuticals

    Aspreva is an emerging pharmaceutical company focused on identifying,
developing and, upon regulatory approval, commercializing new indications for
approved drugs and late stage drug candidates for patients living with less
common diseases. Aspreva is listed on the NASDAQ Global Select Market under
the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading
symbol "ASV".




For further information:

For further information: Sage Baker, VP, Investor Relations & Corporate
Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270,
sbaker@aspreva.com

Organization Profile

ASPREVA PHARMACEUTICALS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890